共 372 条
[1]
Mottet N(2017)EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent Eur Urol 71 618-629
[2]
Bellmunt J(2018)Management of biochemical recurrence after primary curative treatment for prostate cancer: a review Urol Int 100 251-262
[3]
Bolla M(2012)Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations Eur Urol 61 341-349
[4]
Briers E(2012)Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores Eur Urol 61 480-487
[5]
Cumberbatch MG(2018)Prostate specific antigen levels and proportion of biopsy positive cores are independent predictors of upgrading patterns in low risk prostate cancer Minerva Urol Nefrol 98 32-39
[6]
De Santis M(2017)Clinical factors of disease reclassification or progression in a contemporary cohort of prostate cancer patients elected to active surveillance Urol Int 99 207-214
[7]
Fossati N(2017)Clinical factors predicting and stratifying the risk of lymph node invasion in localized prostate cancer Urol Int 99 215-221
[8]
Gross T(2017)Association between basal total testosterone levels and tumor upgrading in low and intermediate risk prostate cancer Urol Int 104 111-115
[9]
Henry AM(2018)Clinical factors stratifying the risk of tumor upgrading to high-grade disease in low-risk prostate cancer Tumori J 101 38-46
[10]
Joniau S(2018)Positive association between preoperative total testosterone levels and risk of positive surgical margins by prostate cancer: results in 476 consecutive patients treated only by radical prostatectomy Urol Int 103 25-32